Device Manufacturers Drive Education In China Amid Looming Tender Expansion
This article was originally published in PharmAsia News
Executive Summary
China’s device market is poised for extraordinary growth with multinational firms such as Johnson & Johnson, Smith & Nephew and Stryker ramping up physician education against a backdrop of regulatory complexity and a possible new central tendering process.
You may also be interested in...
Zimmer Looks To Score Big In Chinese Orthopedic Market With Beijing Montagne Acquisition
U.S.-listed orthopedic device maker Zimmer Inc. says its latest overseas purchase of Beijing Montagne Medical Device Co. Ltd., gives it greater marketing access to the Chinese orthopedic implant market, growing at an estimated 15 percent annually, and a manufacturing base to compete with rivals already in the market
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Chinese Language Podcast: BIOSECURE Act, US PD-1 Approval, ADC Updates
Guest speaker and lawyer Kevin Duan joins Brian Yang and Dexter Yan to discuss the planned US BIOSECURE Act, the US approval of BeiGene's anti-PD-1 drug and the latest antibody-drug conjugates in development at Chinese pharma firms.